Lung Carcinoma Staging Problems - 20/08/11
Doi : 10.1016/j.path.2010.03.008
Philip T. Cagle, MD a, b, ⁎ 
a Department of Pathology and Laboratory Medicine, Weil Medical College of Cornell University, 1300 York Avenue, New York, NY 10065, USA
b Department of Pathology, The Methodist Hospital, Main Building, Room 227B, 6565 Fannin Street, Houston, TX 77030, USA
Department of Pathology, The Methodist Hospital, Main Building, Room 227B, 6565 Fannin Street, Houston, TX 77030.Abstract |
The tumor-node-metastasis (TNM) system is the most commonly used staging system for cancers, including lung cancer. The TNM descriptors and the stage groupings reflect differences in patient prognosis and choices for specific therapies. Generally, the higher the T, N, or M, and the higher the stage grouping, the worse the prognosis is for patients in that category. TNM stage is traditionally the most important factor predicting survival of lung cancer patients.
El texto completo de este artículo está disponible en PDF.Keywords : Lung, Carcinoma, Staging, Tumor-node-metastasis, TNM system
Esquema
© 2010
Elsevier Inc. Reservados todos los derechos.
Vol 3 - N° 1
P. 61-69 - mars 2010 Regresar al número
Artículo precedente
- Pulmonary Neuroendocrine Tumors
- Leslie A. Litzky
- Targeted Therapies in Lung Cancer
- Lucian R. Chirieac, Sanja Dacic
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?